These research collaborations have the power to answer questions critical to improving cancer outcomes, such as how tumors develop drug resistance, and what treatments are most effective against particular genomic traits. (cancer.gov)
For example, bacteria would typically develop drug resistance by evolving a mutation that breaks down the drug. (sciencedaily.com)
Meanwhile, pediatric pulmonologist Luke Hoffman at the University of Washington has found that some bacteria can develop drug resistance in response to an environmental change, without exposure to any antibiotics. (discovermagazine.com)